Diffuse alveolar hemorrhage associated with ustekinumab treatment.

Kulothungan GunasekaranAnant ShuklaNageshwari PalanisamyMandeep Singh RahiArmand Wolff

Published in: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists (2021)

A 46-year-old woman developed DAH during ustekinumab treatment. Symptoms abated after drug discontinuation and supportive treament. Clinicians must remain mindful of this rare complication of ustekinumab use in order to avoid potential delays in appropriate DAH treatment.

Keyphrases

physical activity
combination therapy
replacement therapy
smoking cessation
sleep quality